1254 related articles for article (PubMed ID: 15883113)
21. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
22. Progestogen deficiency and endometrial cancer risk.
Schindler AE
Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
[TBL] [Abstract][Full Text] [Related]
23. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
La Vecchia C
Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
[TBL] [Abstract][Full Text] [Related]
24. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
25. [Breast cancer and the use of the hormones around the menopause].
Vandenbroucke JP; van Leeuwen FE; Helmerhorst FM
Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1829-34. PubMed ID: 14533492
[TBL] [Abstract][Full Text] [Related]
26. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
[TBL] [Abstract][Full Text] [Related]
27. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
28. The pill and the breast.
Drife JO
IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
30. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
31. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and estrogen-dependent cancers.
Birkhäuser M
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
[TBL] [Abstract][Full Text] [Related]
33. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
34. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
35. Exogenous estrogens and other factors in the epidemiology of breast cancer.
Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
[TBL] [Abstract][Full Text] [Related]
36. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
37. [Estrogen replacement therapy and breast cancer].
Bakken K; Alsaker E; Eggen AE; Lund E
Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
[TBL] [Abstract][Full Text] [Related]
38. [Hormone replacement therapy and breast cancer].
Dobashi K
Gan To Kagaku Ryoho; 1999 Jun; 26(7):871-6. PubMed ID: 10396312
[TBL] [Abstract][Full Text] [Related]
39. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
40. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]